ArticleBreast care (Basel, Switzerland)2019

ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany.

Nicolai Maass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.